Court Halts Suspension: Patanjali's 14 Drug Production Resumes

An interim stay was imposed on suspending manufacturing licences of Patanjali Ayurved Ltd and Divya Pharmacy medicines, citing illegal procedures. The Uttarakhand government based the decision on a preliminary inquiry by a high-level committee. The firms challenged last month's suspension under the Drugs and Cosmetics Act 1945 and Drugs and Magic Remedies Act 1954.

An interim stay was put on Friday on the implementation of an order suspending manufacturing licences of more than a dozen medicines of Patanjali Ayurved Ltd and Divya Pharmacy.

The interim stay is being imposed with immediate effect on the basis of a preliminary inquiry report of a high level committee, Pankaj Kumar Pandey, Secretary Ayush, Uttarakhand government said in an order.

''The order of the suspension is illegal and should not have been passed by the licensing authority in the manner it has been passed,'' the committee looking into the matter said in its report.

The firms had challenged the last month's suspension order of the Uttarakhand state licensing authority.

''Since the licence has been cancelled without following the procedure established by law, the committee is submitting its report to the government of Uttarakhand for appropriate decision,'' it said.

The State Licensing Authority, Ayurvedic and Unani Services had suspended the manufacturing licence of 14 Patanjali products last month under Drugs and Cosmetics Act 1945 and Drugs and Magic Remedies (Objectionable Advertisements) Act 1954.

The medicines whose manufacturing licence had been suspended included Swasari Gold, Swasari Vati, Bronchom, Swasari Pravahi, Swasari Avaleh, Mukta Vati Extra Power, Lipidom, BP Grit, Madhugrit, Madhunashini Vati Extra Power, Livamrit Advance, Livogrit, Eyegrit Gold and Patanjali Drishti Eyedrop.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)